Clinical Trial: Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as A Part of Bismuth Based Quadruple Therapy for Treatment of Helicobacter Pylori Infection

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07165444) titled 'Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as A Part of Bismuth Based Quadruple Therapy for Treatment of Helicobacter Pylori Infection' on Sept. 03.

Brief Summary: This study aims to compare the eradication rate, safety, and patient adherence between potassium-competitive acid blockers (P-CABs) and proton pump inhibitor-based bismuth quadruple therapy in patients with Helicobacter pylori infection.

Study Start Date: Sept. 15

Study Type: INTERVENTIONAL

Condition: Potassium-Competitive Acid Blocker Proton Pump Inhibitor Bismuth Based Quadruple Therapy Treatment Helicobacter Pylori Infection

Intervention: DR...